Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E. (Q45046442)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 July 2012

Language	Label	Description	Also known as
English	Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E.	scientific article published on 26 July 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

0 references

phase III clinical trial

0 references

25

object named as

Merlin L Robb

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

24

object named as

Nelson L Michael

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

27

object named as

Jerome H Kim

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Supachai Rerks-Ngarm

1

object named as

Supachai Rerks-Ngarm

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Peter B Gilbert

26

object named as

Peter B Gilbert

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Rapee Trichavaroj

9

object named as

Rapee Trichavaroj

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

21

object named as

Viseth Ngauy

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sorachai Nitayaphan

20

object named as

Sorachai Nitayaphan

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sanjay Gurunathan

16

object named as

Sanjay Gurunathan

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Charla A Andrews

12

object named as

Charla Andrews

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

4

object named as

Nakorn Premsri

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Prayura Kunasol

23

object named as

Prayura Kunasol

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

James Tartaglia

17

object named as

Jim Tartaglia

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Chirapa Eamsila

19

object named as

Chirapa Eamsila

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Chawetsan Namwat

5

object named as

Chawetsan Namwat

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Chureeratana Bowonwatanuwong

6

object named as

Chureeratana Bowonwatanuwong

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Robert M Paris

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Supamit Chunsutthiwat

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Shuying S Li

7

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Jaranit Kaewkungkal

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Nampueng Churikanont

10

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Mark S de Souza

11

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Donald Francis

13

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Elizabeth Adams

14

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Jorge Flores

15

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Robert J O'Connell

18

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Prasert Thongcharoen

22

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

language of work or name

0 references

publication date

26 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

207

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

1195-1205

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Antibody neutralization and escape by HIV-1

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Vaccines: correlates of vaccine-induced immunity

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

The role of antibodies in HIV vaccines

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Tight regulation of memory CD8(+) T cells limits their effectiveness during sustained high viral load

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

How Innate Immune Mechanisms Contribute to Antibody-Enhanced Viral Infections

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Screening and evaluation of potential volunteers for a phase III trial in Thailand of a candidate preventive HIV vaccine (RV148).

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Sensitivity Analyses Comparing Time-to-Event Outcomes Existing Only in a Subset Selected Postrandomization

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Use of predictive markers of HIV disease progression in vaccine trials

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Recent observations on HIV type-1 infection in the genital tract of men and women

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Is the male genital tract really a sanctuary site for HIV? Arguments that it is not.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS478

21 January 2018

Identifiers

10.1093/INFDIS/JIS478

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45046442&oldid=2034574189"